R&D News | pharmaphorum

News

Moderna shines spotlight on new flu vaccine data

Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes.

News

INmune Bio slumps on midstage fail for Alzheimer's drug

INmune Bio's bid to develop an Alzheimer's drug with a new mechanism of action has been dented, but the company remains upbeat.

News

A hand holding a blackboard with the chalk-written word POSSIBLE

Novo Nordisk Foundation gives $75m for R&D 'challenges'

The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.

News

Controversial project aims to make artificial human genomes

A landmark project funded by Wellcome aims to develop the tools needed to synthesise human genomes – and simultaneously probe the social implications.

News

Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen

After winding up its stem cell therapy operations last month, Vor Bio has reinvented itself as an autoimmune disease-focused biotech.

News

Nektar eyes pivotal trials for eczema drug cast off by Lilly

Nektar Therapeutics has said phase 2b results show it was right to keep faith with rezpegaldesleukin as a therapy for atopic dermatitis.

Moderna shines spotlight on new flu vaccine data

INmune Bio slumps on midstage fail for Alzheimer's drug

Novo Nordisk Foundation gives $75m for R&D 'challenges'

Controversial project aims to make artificial human genomes

Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen

Nektar eyes pivotal trials for eczema drug cast off by Lilly

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks